Sol-Gel Technologies Ltd.

General ticker "SLGL" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $987.0M (TTM average)

Sol-Gel Technologies Ltd. follows the US Stock Market performance with the rate: 40.2%.

Estimated limits based on current volatility of 5.0%: low 70.68$, high 78.10$

Factors to consider:

  • Total employees count: 49 as of 2017
  • Current price 50.6% above estimated high
  • Earnings for 3 months up through Q1 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [17.36$, 47.46$]
  • 2026-12-31 to 2027-12-31 estimated range: [11.07$, 31.38$]

Financial Metrics affecting the SLGL estimates:

  • Negative: with PPE of -37.7 at the end of fiscal year the price was very high
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: negative Industry operating cash flow (median)
  • Negative: -0.75 < Inventory ratio change, % of 0
  • Negative: Shareholder equity ratio, % of 76.25 > 64.29

Similar symbols

Short-term SLGL quotes

Long-term SLGL plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $1.55MM $11.54MM $19.39MM
Operating Expenses $30.86MM $23.55MM $26.98MM
Operating Income $-29.30MM $-12.01MM $-7.59MM
Non-Operating Income $2.07MM $1.43MM $1.47MM
R&D Expense $23.54MM $17.80MM $22.70MM
Income(Loss) $-27.24MM $-10.58MM $-6.13MM
Net Income(Loss)* $-27.24MM $-10.58MM $-6.13MM
Stockholders Equity $38.64MM $28.85MM $22.81MM
Assets $45.29MM $35.85MM $29.92MM
Operating Cash Flow $-17.73MM $-13.89MM $0.32MM
Capital expenditure $0.13MM $0.00MM $0.05MM
Investing Cash Flow $-9.74MM $26.69MM $-8.58MM
Financing Cash Flow $21.81MM $0.00MM $0.01MM
Earnings Per Share** $-1.01 $-0.38 $-2.20

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.